Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Older Patients (pts) With Treatment-Naive Chronic Lymphocytic Leukemia (CLL) Treated With Ibrutinib (ibr): Prolonged Improvement in Patient-Reported Outcomes (PROs) and Well-being in RESONATE-2 Owen, C., Tedeschi, A., Coutre, S., Dean, J. P., Burger, J. A., Kipps, T. J. WILEY. 2018: S127
View details for Web of Science ID 000430468400375